ArticleFrontiers in immunology2024

Intranasal administration of a synthetic TLR4 agonist INI-2004 significantly reduces allergy symptoms following therapeutic administration in a murine model of allergic sensitization.

Konner J Jackson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.